A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Clinical trial NCT06966479 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06966479
- Sponsor
- Upstream Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-21
- Primary completion
- 2027-09-01
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.